Meril Life Sciences Private Limited, a active private limited company, was established on 19 June 2007 in Vapi, Gujarat, India. Engaging in medical & laboratory equipment within the manufacturing sector, it holds CIN: U24239GJ2007PTC051137. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹100.00 Cr and a paid-up capital of ₹99.36 Cr.
It upholds a compliant status. Employing 1,584 professional, Its leadership includes Nanubhai Premjibhai Bambharolia (Whole-Time Director), Rajnikant Gandalal Vyas (Whole-Time Director), Hemchandra Yadunandan Panjikar (Director). Past directors included Mustufa Makwana, Nanubhai Premjibhai Bambharolia, Pramodkumar Minocha. It holds ₹788.45 Cr open charges and ₹228.76 Cr settled loans. Its latest AGM occurred on 30 July 2025, with the balance sheet filed on 31 March 2025. It is based at Bilakhia House, Survey No. 135/139, Muktanand Marg, Chala,, Vapi, Gujarat, 396191.
U24239GJ2007PTC051137
051137
19 June 2007
₹100.00 Cr
₹99.36 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Meril Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nanubhai Premjibhai Bambharolia | Whole-Time Director | 19 Jun 2007 | Current |
| Rajnikant Gandalal Vyas | Whole-Time Director | 20 Oct 2010 | Current |
| Hemchandra Yadunandan Panjikar | Director | 11 Mar 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Director | 01 Jan 2013 | Past |
| Pramod Abcsdd | Additional Director | 22 Mar 2011 | Past |
| Pramod Abcsdd | Company Secretary | 07 Mar 2020 | Past |
| Pramod Abcsdd | Additional Director | 25 Jan 2008 | Past |
| Pramod Abcsdd | Director | 20 Oct 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Meril Life Sciences Private Limited, for the financial year ended 2025, experienced significant growth in revenue, with a 43.8% increase. The company also saw a substantial improvement in profitability, with a 134.91% increase in profit. The company's net worth Soared by an impressive increase of 60.95%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Meril Life Sciences had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹7,884,500,000.00
₹2,287,560,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Nov 2024 | Others | ₹144.00 Cr | Open |
| 13 Jun 2023 | Others | ₹146.00 Cr | Open |
| 28 Sep 2021 | Others | ₹110.00 Cr | Open |
| 25 Jun 2019 | Hdfc Bank Limited | ₹120.00 Cr | Open |
| 07 Jun 2019 | Others | ₹20.00 Cr | Open |
Explore comprehensive loan charge details -
Meril Life Sciences has a workforce of 1584 employees as of Sep 25, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Meril Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meril Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Meril Life Sciences Private Limited last Annual general meeting of members was held on 30 Jul 2025 as per latest MCA records. was recorded as a recent event.
Progress on Meril Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.
The activity A charge with Others amounted to Rs. 144.00 Cr with Charge ID 101013269 was registered on 15 Nov 2024. was completed.
Progress on A charge registered on 24 May 2021 via Charge ID 100450226 with Others was fully satisfied on 19 Jul 2024. was documented.
Progress on A charge with Others of Rs. 20.00 Cr registered on 07 Jun 2019 with Charge ID 100270162 was modified on 29 Jun 2024. was documented.
The activity A charge with Hdfc Bank Limited of Rs. 120.00 Cr registered on 25 Jun 2019 with Charge ID 100273444 was modified on 04 Jun 2024. was completed.
Panel to decide if Sun Pharma’s anti-cancer drug, Meril’s biodegradable stent have therapeutic advantage.Mumbai-based Sun Pharmaceuticals is seeking an exemption for its anti-cancer gemcitabine hydrochloride injection.
Meril has developed MeRes100, which it claims is the country's first locally made bioresorbable vascular scaffold, or naturally dissolving stent for clearing blockages in arteries.
The CIN of Meril Life Sciences Private Limited is U24239GJ2007PTC051137.
Meril Life Sciences Private Limited is headquartered at Bilakhia House, Survey No. 135/139, Muktanand Marg, Chala,, Vapi, Gujarat, 396191.
Meril Life Sciences Private Limited was incorporated on 19 June 2007.
The current directors of Meril Life Sciences Private Limited are
The primary industry of Meril Life Sciences Private Limited is Manufacturing.
Meril Life Sciences Private Limited is unlisted.
The authorized capital of Meril Life Sciences Private Limited is ₹100.00 Cr, and the paid-up capital is ₹99.36 Cr.
The compliance status of Meril Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX